OTCMWTKWY
Market cap38bUSD
Dec 20, Last price
167.39USD
1D
0.69%
1Q
-3.15%
Jan 2017
361.13%
Name
Wolters Kluwer NV
Chart & Performance
Profile
Wolters Kluwer N.V. provides professional information, software solutions, and services in the Netherlands, rest of Europe, the United States, Canada, the Asia Pacific, and internationally. The company operates through four segments: Health; Tax & Accounting; Governance, Risk & Compliance; and Legal & Regulatory. The Health segment offers clinical technology and evidence-based solutions that drive effective decision-making and improved outcomes across healthcare. It provides solutions for hospitals, clinics, other healthcare providers, individual clinicians and students, nursing and medical schools and libraries, retail pharmacies, payers, and life sciences organizations. The Tax & Accounting segment offers solutions that help tax, accounting, and audit professionals to drive productivity, navigate change, and deliver better outcomes. It provides solutions for accounting firms, corporate finance, tax and auditing departments, government agencies, libraries, and universities. The Governance, Risk & Compliance segment offers technology-enabled services and solutions for legal entity compliance, legal operations management, banking product compliance, and regulatory reporting. It serves legal, compliance, and risk professionals in corporations, small businesses, law firms, insurers, banks, non-bank lenders, credit unions, leasing companies, and securities firms. The Legal & Regulatory segment provides evidence-based information, actionable insights, and integrated workflow solutions that help customers to make the right decisions and streamline compliance. It enables legal and compliance professionals, and operational risk managers, as well as environmental, health, and safety managers to improve productivity and performance, mitigate risk, and solve complex problems with confidence in law firms, corporations, universities, and government agencies. Wolters Kluwer N.V. was founded in 1836 and is based in Alphen aan den Rijn, the Netherlands.
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | 2014‑12 | |
Income | ||||||||||
Revenues | 5,584,000 2.40% | 5,453,000 14.29% | 4,771,000 3.65% | |||||||
Cost of revenue | 4,254,000 | 4,850,000 | 4,294,000 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 1,330,000 | 603,000 | 477,000 | |||||||
NOPBT Margin | 23.82% | 11.06% | 10.00% | |||||||
Operating Taxes | 290,000 | 249,000 | 201,000 | |||||||
Tax Rate | 21.80% | 41.29% | 42.14% | |||||||
NOPAT | 1,040,000 | 354,000 | 276,000 | |||||||
Net income | 1,007,000 -1.95% | 1,027,000 41.07% | 728,000 0.97% | |||||||
Dividends | (467,000) | (424,000) | (373,000) | |||||||
Dividend yield | 1.48% | 1.70% | 1.38% | |||||||
Proceeds from repurchase of equity | (1,000,000) | (505,000) | (399,000) | |||||||
BB yield | 3.16% | 2.02% | 1.47% | |||||||
Debt | ||||||||||
Debt current | 659,000 | 785,000 | 80,000 | |||||||
Long-term debt | 3,358,000 | 2,830,000 | 3,051,000 | |||||||
Deferred revenue | 102,000 | 112,000 | 113,000 | |||||||
Other long-term liabilities | 86,000 | 334,000 | 357,000 | |||||||
Net debt | 2,847,000 | 2,218,000 | 2,096,000 | |||||||
Cash flow | ||||||||||
Cash from operating activities | 1,545,000 | 1,582,000 | 1,292,000 | |||||||
CAPEX | (324,000) | (295,000) | (240,000) | |||||||
Cash from investing activities | (374,000) | (299,000) | (287,000) | |||||||
Cash from financing activities | (1,481,000) | (991,000) | (451,000) | |||||||
FCF | 1,224,000 | 237,000 | 104,000 | |||||||
Balance | ||||||||||
Cash | 1,135,000 | 1,346,000 | 1,001,000 | |||||||
Long term investments | 35,000 | 51,000 | 34,000 | |||||||
Excess cash | 890,800 | 1,124,350 | 796,450 | |||||||
Stockholders' equity | 2,283,000 | 2,958,000 | 2,577,000 | |||||||
Invested Capital | 4,791,200 | 4,873,650 | 4,819,550 | |||||||
ROIC | 21.52% | 7.30% | 5.78% | |||||||
ROCE | 22.30% | 9.37% | 7.87% | |||||||
EV | ||||||||||
Common stock shares outstanding | 246,000 | 255,800 | 261,800 | |||||||
Price | 128.70 31.65% | 97.76 -5.64% | 103.60 50.01% | |||||||
Market cap | 31,660,200 26.61% | 25,007,008 -7.80% | 27,122,480 47.31% | |||||||
EV | 34,507,200 | 27,225,008 | 29,218,480 | |||||||
EBITDA | 1,770,000 | 1,035,000 | 898,000 | |||||||
EV/EBITDA | 19.50 | 26.30 | 32.54 | |||||||
Interest | 27,000 | 69,000 | 65,000 | |||||||
Interest/NOPBT | 2.03% | 11.44% | 13.63% |